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EDITORIALS
PDE8: A Novel Target in Airway Smooth Muscle
The ubiquitous second messenger 39,59-cAMP acts as a key player
in the signaling cascades that control many physiological and
pathophysiological processes in the lung. The intracellular
concentrations of cAMP are determined by its production, which
is regulated by G-protein–coupled receptors and adenylyl
cyclases (ACs), and its degradation by phosphodiesterases (PDEs),
which include 11 family members (PDE1–PDE11) and at least
21 isoforms with different splice variants (1). PDEs hydrolyze
cyclic nucleotides (cAMP and cGMP) to inactivate 59
monophosphates within subcellular microdomains, thereby
modulating cyclic nucleotide signaling pathways. PDE4, PDE7, and
PDE8 are cAMP speciﬁc, whereas PDE5, PDE6, and PDE9 are
cGMP speciﬁc. The remaining family members can degrade both
cyclic nucleotides, although they prefer one or the other to varying
degrees.
PDE4, the most extensively studied cAMP-speciﬁc PDE, is
highly expressed in airway smooth muscle (ASM) cells. Many
studies have provided important information regarding the
functions of PDE4 in ASM cells, especially in regulating cell
proliferation, contraction, and migration (2–5). A-kinase anchoring
proteins (AKAPs) also contribute to spatial and temporal cAMP
dynamics by binding directly to protein kinase A (PKA) and its
target proteins, thus physically tethering these multiprotein
complexes to speciﬁc locations in the cells (6). It has been
demonstrated that gravin (AKAP250) is able to tether PKA and
PDE4D to b2-adrenoceptor (b2-AR) at the plasma membrane in
human embryonic kidney cells, highlighting the importance of
compartmentalized cAMP signaling (7). Inhibition of another
cAMP-speciﬁc enzyme, PDE7, is also believed to induce a variety of
cellular effects due to increased cAMP accumulation. BRL50481, a
PDE7-selective inhibitor, can relax the airways after histamine-
induced contraction in the ovalbumin-sensitized guinea pig model
(8). Moreover, the inhibition of PDE7 augments the inhibitory
effect of other cAMP-elevating drugs on proinﬂammatory cells
without having such an effect itself (9). However, surprisingly, the
role and location of PDE8, a less widely expressed PDE member
that has greater cAMP afﬁnity than PDE4, have not yet been
studied in ASM cells.
In this issue of the Journal, Johnstone and colleagues (pp.
530–541) demonstrate for the ﬁrst time the transcript, protein,
and functional presence of PDE8 in human ASM cells and report
on a functional b2-AR-AC6-PDE8 signalosome expressed in
caveolae (10). To study the functional role of PDE8, they used
dipyridamole, a semiselective PDE5/8 inhibitor, to enhance cAMP
accumulation after forskolin stimulation in human ASM cells
overexpressing either AC2 or AC6. They found that increased
cAMP levels were restricted to ASM cells overexpressing AC6. The
authors conﬁrmed this ﬁnding by using shRNA knockdown of
PDE8A, which indicated that PDE8A was able to hydrolyze
cAMP speciﬁcally when induced by AC6, with little interference on
AC2-induced cAMP generation. Most intriguingly, their study
revealed that PDE8 inhibition selectively increased cAMP levels
that were generated in response to b2-AR stimulation, but had no
effect when E-prostanoid 2 (EP2) or EP4 receptors were activated.
Thus, PDE8 inhibition, together with b2-AR stimulation, reduced
serum-induced human ASM cell proliferation, whereas PDE8
inhibition had no such effect on prostaglandin E2. Modulation of
PDE8 activity in human ASM cells may enhance the effect of
b2-AR signaling on bronchodilation as well, but this needs to be
further established in future studies.
Nowadays, several cAMP biosensors are used to visualize
cAMP ﬂuctuations in living cells with high temporal and spatial
resolution (11). After almost two decades, the ﬂuorescence
resonance energy transfer–based cAMP sensors are well developed
and widely used to study cAMP dynamics. To monitor cAMP
dynamics in the present study, Johnstone and colleagues used
another novel genetically encoded cAMP biosensor, named cAMP
Difference Detector in situ (cADDis), which employs a much easier
standard ﬂuorescent plate reader (10). In contrast to the classical
two-ﬂuorophore ﬂuorescence resonance energy transfer–based
cAMP biosensor, cADDis is composed of one circularly permuted
GFP and a cAMP-binding domain of an exchange protein
directly activated by cAMP (EPAC) 2, which makes it possible to
be paired with other colored sensors for multiplex recordings, such
as red Ca21 sensors (12). Using this sensor, the authors were able
to show that the PDE8-selective inhibitor PF-04957325 had
strikingly large effects on cAMP in ASM, indicating that PDE8
activity is at least as important as PDE4 in modulating cAMP
dynamics in human ASM cells. Therefore, PDE8 may have
therapeutic value in respiratory diseases such as asthma and
chronic obstructive pulmonary disease.
Several intriguing questions arise from this study that
require further investigation. cAMP has been shown to regulate
the ASM contractile state, secretion of inﬂammatory cytokines
and chemokines, and cell proliferation and migration (13).
Therefore, it is important to examine the effect of PDE8 inhibition
on these responses in further detail in both in vitro and
in vivo experimental models. Moreover, AKAPs, as some of the
most important elements in cAMP compartments, play a vital
role in modulating cAMP spatial and temporal dynamics. Thus,
it is rational to explore the role of different AKAP members
in controlling PDE8 activity and localization. The present
study shows the colocalization of PDE8 with b2-AR-AC6 in
caveolae.
In conclusion, this study by Johnstone and colleagues
(10) reveals for the ﬁrst time the selective role of PDE8 in
limiting b2-AR-AC6–mediated cAMP signaling in human
ASM cells, and motivates further exploration of the functional
outcomes of PDE8 inhibition. As one of the most predominant
cAMP-hydrolyzing PDEs in human ASM cells, PDE8
seems to be a therapeutic target worth pursuing in respiratory
diseases. n
Author disclosures are available with the text of this article at
www.atsjournals.org.
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